Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
EYP-651 by Enyo Pharma for Metabolic Dysfunction-Associated Steatohepatitis (MASH): Likelihood of Approval
EYP-651 is under clinical development by Enyo Pharma and currently in Phase II for Metabolic Dysfunction-Associated Steatohepatitis (MASH). According to...
EYP-651 by Enyo Pharma for Diabetic Nephropathy: Likelihood of Approval
EYP-651 is under clinical development by Enyo Pharma and currently in Phase I for Diabetic Nephropathy. According to GlobalData, Phase...
EYP-651 by Enyo Pharma for Chronic Kidney Disease (Chronic Renal Failure): Likelihood of Approval
EYP-651 is under clinical development by Enyo Pharma and currently in Phase II for Chronic Kidney Disease (Chronic Renal Failure)....